Emraclidine's failure in phase 2 trials is a significant setback for AbbVie's neuroscience pipeline. This was a very ...

When you have a conversation today, notice the natural points when the exchange leaves open the opportunity for the other ...

Intel admits that its Core Ultra 9 285K and Core Ultra 5 245K have problems, but it plans to address the issues with a ...

Neuralink’s brain-computer interface ... “It’s great that Elon is focused on this problem. It’s hard to see where the ceiling ...

Readers' emotions on the election are mixed. One reader calls for Americans to unify and move forward, but others wonder what ...

While they hold medical promise, their potential to enhance abilities raises concerns about privacy, control, and the very essence of being human. As BCs advance, will they become indispensable, ...

Sarepta Therapeutics has ended development of a late-phase Duchenne muscular dystrophy (DMD) drug candidate over a safety problem. The safety signal deprived Sarepta of a near-term shot at accelerated ...

Elon Musk — the billionaire CEO of Tesla, SpaceX, and xAI, and the owner of The Boring Company, Neuralink, and X — took a sharp swing to the right this election to support President-elect Donald Trump ...

Christina JewettThere are now artificial intelligence programs that scan MRIs for signs of cancer, Apple AirPods that work as ...